Optometry News

Healio’s recent stories in glaucoma include the de novo classification of an ocular pressure adjusting pump and promising results with timolol microdrops to lower IOP.

In 2024, the discussion around AI’s role in medicine continues to grow, including in eye care.

On June 25, 1984, the Supreme Court settled the case of Chevron U.S.A. Inc. v. Natural Resources Defense Council Inc.

In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, explain what a Google Business Profile is and why practices should claim and update their profile.

Okyo Pharma released new data from its phase 2 trial of OK-101, a lipid conjugated chemerin peptide agonist, which showed a 68% improvement in both conjunctival staining and ocular pain among patients with dry eye disease.

Hi, I'm Yari, and I have questions. And this is Dr. Doug Koch, and he has answers. Let's see if they match!

More research is needed to improve diagnosis of dry eye disease in children, as well as to determine the safety and efficacy of treatment options in this population, according to a literature review published in The Ocular Surface.

A review of currently available data suggests that there is little or no difference in efficacy and safety between anti-VEGF biosimilars approved for neovascular age-related macular degeneration and their reference products.

CMS has released its proposed 2025 Medicare Physician Fee Schedule, or PFS, which includes a 2.93% cut in physician payments from the previous year, according to a press release.

DocGo and Spect have partnered to provide mobile health clinicians a more cost-effective way to screen patients at home for diabetic retinopathy and other eye diseases, according to a DocGo press release.